Welgene Biotech Co., Ltd. (6661)
Market Closed
16 Oct, 05:30 AM
TWSE 
HKEX Primary TWSE NT$
17. 00
-0.25
-1.4493%
NT$
- Market Cap
- P/E Ratio
1.2% Div Yield
3,007 Volume
- Eps
NT$ 17.25
Previous Close Want to track 6661 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Welgene Biotech Co., Ltd. (6661) Statistics
Valuation metrics
Market Cap -
Enterprise value 513M
Trailing P/E (ttm) -251.83
Forward P/E -
PEG ratio 3.82
Price/Sales (ttm) 1
Price/Book (mrq) 1.53
Enterprise Value/Revenue 1.29
Enterprise Value/EBITDA 16.59
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1K
Average volume (90 days) 4.12K
Price summary
52-Week low 15.5
52-Week high 20.35
Beta -
50-Day moving average 16.58
200-Day moving average 17.42
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 3 Jul 2026
Ex-Dividend Date 9 Jun 2026
Last split factor 1,080:1,000
Last split Date 17 Aug 2018
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0%
Operating margin -0.01%
Operational effectiveness
Return on assets -0%
Return on equity -0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 16.39
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.3
Total debt (mrq) -
Total Debt/Equity (mrq) 1.03
Current ratio (mrq) 1.91%
Book value per share (mrq) 11.41
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
